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The DAMOCLES project established a Data Monitoring
Committee Charter which has been widely used for ran-
domised controlled trials since 2005. As established
within DAMOCLES, the DMC is typical advisory, making
recommendations to another executive body; considered
the Trial Steering Committee. No evidence-based Charter
exists for TSCs to establish their role and functionality in
RCTs.
The MRC Guidelines for Good Clinical Practice
(1998) defines a three committee oversight structure:
the day-to-day Trial Management Group, the DMC and
the executive TSC. The document provides brief Terms
of Reference for TSCs and represents the first attempt
at guidance on TSC remit and structure. It is not
known whether or how extensively this document has
been used to inform TSC-like current roles and practice.
There is acknowledged variation in practice in the UK
and, moreover, internationally.
The aim of this project was to re-visit the MRC Terms
of Reference and provide dedicated guidance on TSC
remit and structure by producing a comprehensive Terms
of Reference and Charter that will promote a systematic
and transparent approach to the oversight of RCTs.
To inform this development, a survey to establish
current practice and requirements within UK registered
Clinical Trials Units has been undertaken. A cohort of
published RCTs within medical journals and HTA
monographs has been obtained to determine how TSC
activities are currently reported and the literature reviewed
to identify case studies of TSC activity in RCT conduct.
Results of this work will be presented with how these
findings impact development of more complete guidelines.
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